Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The European Respiratory Journal|January 15, 2021
Serum and pulmonary uric acid in pulmonary arterial hypertensionLaurent Savale, Satoshi Akagi, Ly Tu, et al.
Circulation|April 25, 2023
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial HypertensionChristophe Guignabert, Laurent Savale, Athénaïs Boucly, et al.
Journal of Dental Sciences|January 14, 2025
Identify characteristics of Vietnamese oral squamous cell carcinoma patients by machine learning on transcriptome and clinical-histopathological analysisHuong Thu Duong, Nam Cong-Nhat Huynh, Chi Thi-Kim Nguyen, et al.
Scientific Reports|July 19, 2022
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6RαZongye Cai, Siyu Tian, Theo Klein, et al.
American Journal of Respiratory and Critical Care Medicine|January 14, 2016
Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 CleavageRobert Szulcek, Chris M Happé, Nina Rol, et al.
American Journal of Respiratory Cell and Molecular Biology|March 28, 2024
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell DysfunctionHélène Le Ribeuz, Anaïs Saint-Martin Willer, Benoit Chevalier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2024
NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivityGuillaume Cardouat, Matthieu Douard, Clément Bouchet, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
Pageof 9